{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:54:22Z","timestamp":1792090462826,"version":"4.4.0"},"reference-count":97,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Objective: The Androgen Excess Society (AES) charged a task force to review all available data and recommend an evidence-based definition for polycystic ovary syndrome (PCOS), whether already in use or not, to guide clinical diagnosis and future research.<\/jats:p>\n                  <jats:p>Participants: Participants included expert investigators in the field.<\/jats:p>\n                  <jats:p>Evidence: Based on a systematic review of the published peer-reviewed medical literature, by querying MEDLINE databases, we tried to identify studies evaluating the epidemiology or phenotypic aspects of PCOS.<\/jats:p>\n                  <jats:p>Consensus Process: The task force drafted the initial report, following a consensus process via electronic communication, which was then reviewed and critiqued by the AES Board of Directors. No section was finalized until all members were satisfied with the contents and minority opinions noted. Statements that were not supported by peer-reviewed evidence were not included.<\/jats:p>\n                  <jats:p>Conclusions: Based on the available data, it is the view of the AES Task Force on the Phenotype of PCOS that there should be acceptance of the original 1990 National Institutes of Health criteria with some modifications, taking into consideration the concerns expressed in the proceedings of the 2003 Rotterdam conference. A principal conclusion was that PCOS should be first considered a disorder of androgen excess or hyperandrogenism, although a minority considered the possibility that there may be forms of PCOS without overt evidence of hyperandrogenism but recognized that more data are required before validating this supposition. Finally, the task force recognized, and fully expects, that the definition of this syndrome will evolve over time to incorporate new research findings.<\/jats:p>","DOI":"10.1210\/jc.2006-0178","type":"journal-article","created":{"date-parts":[[2006,8,30]],"date-time":"2006-08-30T04:31:02Z","timestamp":1156912262000},"page":"4237-4245","source":"Crossref","is-referenced-by-count":1757,"title":["Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline"],"prefix":"10.1210","volume":"91","author":[{"given":"Ricardo","family":"Azziz","sequence":"first","affiliation":[{"name":"Cedars-Sinai Medical Center and The David Geffen School of Medicine at University of California, Los Angeles (R.A.), Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Carmina","sequence":"additional","affiliation":[{"name":"University of Palermo (E.C.), 90128 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Dewailly","sequence":"additional","affiliation":[{"name":"Lille University Hospital (D.D.), 59037 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Diamanti-Kandarakis","sequence":"additional","affiliation":[{"name":"University of Athens Medical School (E.D.-K.), GR-157 84 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector F.","family":"Escobar-Morreale","sequence":"additional","affiliation":[{"name":"Hospital Ramon y Cajal and University of Alcala\u0301 (H.F.E.-M.), 28801 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Futterweit","sequence":"additional","affiliation":[{"name":"Mount Sinai School of Medicine (W.F.), New York, New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onno E.","family":"Janssen","sequence":"additional","affiliation":[{"name":"University of Essen (O.E.J.), 45131 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Legro","sequence":"additional","affiliation":[{"name":"Pennsylvania State University School of Medicine (R.S.L.), Hershey, Pennsylvania 17033"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Norman","sequence":"additional","affiliation":[{"name":"University of Adelaide (R.J.N.), Woodville, South Australia 5005, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development (A.E.T.), Groton, Connecticut 06340"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma F.","family":"Witchel","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Pittsburgh (S.F.W.), Pittsburgh, Pennsylvania 15213"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613493549900_R1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhoea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"2020071613493549900_R2","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/humrep\/17.9.2219","article-title":"What is polycystic ovary syndrome? Are national views important?","volume":"17","author":"Balen","year":"2002","journal-title":"Hum Reprod"},{"key":"2020071613493549900_R3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jc.2005-2501","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria","volume":"91","author":"Franks","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R5","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R7","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1210\/jcem.87.5.8513","article-title":"Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R8","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/jc.2002-021499","article-title":"Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome","volume":"88","author":"Yildiz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R9","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992","journal-title":"In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;"},{"key":"2020071613493549900_R10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"2020071613493549900_R12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00011","article-title":"A review of the evidence for overlap among unexplained clinical conditions","volume":"134","author":"Aaron","year":"2001","journal-title":"Ann Intern Med"},{"key":"2020071613493549900_R13","unstructured":"Agency for Healthcare Research and Quality 2001 Defining and managing chronic fatigue syndrome. Summary, Evidence Report\/Technology Assessment 42. Rockville, MD (http:\/\/www.ahrq.gov\/clinic\/epcsums\/cfssum.htm)"},{"key":"2020071613493549900_R14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bpg.2004.04.012","article-title":"Definition and epidemiology of functional gastrointestinal disorders","volume":"18","author":"Corazziari","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2020071613493549900_R15","first-page":"130","article-title":"[Comparison of 3 working definitions of metabolic syndrome in male medical examinees]","volume":"30","author":"Feng","year":"2005","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"2020071613493549900_R16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2337\/diacare.26.3.575","article-title":"A comparison of the prevalence of the metabolic syndrome using two proposed definitions","volume":"26","author":"Ford","year":"2003","journal-title":"Diabetes Care"},{"key":"2020071613493549900_R17","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2020071613493549900_R18","first-page":"37","article-title":"Generation of classification criteria for chronic fatigue syndrome using an artificial neural network and traditional criteria set","volume":"16","author":"Linder","year":"2002","journal-title":"In Vivo"},{"key":"2020071613493549900_R19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1464-5491.2004.01115.x","article-title":"WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with type 2 diabetes","volume":"21","author":"Marchesini","year":"2004","journal-title":"Diabet Med"},{"key":"2020071613493549900_R20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1191\/096120399680411317","article-title":"The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement","volume":"8","author":"Smith","year":"1999","journal-title":"Lupus"},{"key":"2020071613493549900_R21","first-page":"919","article-title":"Definition and classification of the antiphospholipid syndrome","volume":"40","author":"Wiedermann","year":"1999","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"2020071613493549900_R22","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"key":"2020071613493549900_R23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0015-0282(16)35047-6","article-title":"Clinical and biochemical features of polycystic ovarian disease","volume":"14","author":"Goldzieher","year":"1963","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/pgmj.59.687.17","article-title":"The aetiology of oligomenorrhoea and\/or hirsuties: a study of 467 patients","volume":"59","author":"Ferriman","year":"1983","journal-title":"Postgrad Med J"},{"key":"2020071613493549900_R25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/09513599609012818","article-title":"Hyperinsulinemia in the polycystic ovary syndrome: a clinical, endocrine and echographic study in 240 patients","volume":"10","author":"Falsetti","year":"1996","journal-title":"Gynecol Endocrinol"},{"key":"2020071613493549900_R26","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1590\/S1516-31801996000400006","article-title":"Polycystic ovary syndrome: clinical and laboratory evaluation","volume":"114","author":"Khoury","year":"1996","journal-title":"Sao Paulo Med J"},{"key":"2020071613493549900_R27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0015-0282(98)00141-1","article-title":"Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama","volume":"70","author":"Azziz","year":"1998","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/eje.0.1390421","article-title":"Prevalence of idiopathic hirsutism","volume":"139","author":"Carmina","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2020071613493549900_R29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2020071613493549900_R30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0020-7292(01)00454-4","article-title":"Ovarian size and response to laparoscopic ovarian electro-cauterization in polycystic ovarian disease","volume":"74","author":"Alborzi","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"2020071613493549900_R31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1479-828X.2001.tb01210.x","article-title":"The impact of ethnicity on the presentation of polycystic ovarian syndrome","volume":"41","author":"Williamson","year":"2001","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"2020071613493549900_R32","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/17.6.1616","article-title":"An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries","volume":"17","author":"Amer","year":"2002","journal-title":"Hum Reprod"},{"key":"2020071613493549900_R33","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1210\/jcem.87.6.8608","article-title":"Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome","volume":"87","author":"Haddad","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R34","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"2020071613493549900_R35","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1210\/jc.2002-021816","article-title":"Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome","volume":"88","author":"Orio Jr","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R36","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups","volume":"83","author":"Chang","year":"2005","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R37","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1055\/s-2005-870236","article-title":"Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia","volume":"37","author":"Hahn","year":"2005","journal-title":"Horm Metab Res"},{"key":"2020071613493549900_R38","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients","volume":"30","author":"Conway","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613493549900_R41","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod"},{"key":"2020071613493549900_R42","author":"Legro","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R43","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R44","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2265.2005.02256.x","article-title":"Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)","volume":"62","author":"Kumar","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613493549900_R45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/jc.2003-030680","article-title":"Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods","volume":"89","author":"Miller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R46","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.clinbiochem.2004.12.001","article-title":"Validation of 5 routine assays for serum free testosterone with a candidate reference measurement procedure based on ultrafiltration and isotope dilution-gas chromatography-mass spectrometry","volume":"38","author":"Van Uytfanghe","year":"2005","journal-title":"Clin Biochem"},{"key":"2020071613493549900_R48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","article-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases","volume":"32","author":"Kiddy","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613493549900_R49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2265.1995.tb02035.x","article-title":"Prevalence of an immunological LH beta-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome","volume":"43","author":"Rajkhowa","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613493549900_R50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0015-0282(16)57364-6","article-title":"Metabolic approaches to the subclassification of polycystic ovary syndrome","volume":"63","author":"Norman","year":"1995","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R51","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1210\/jc.2004-2301","article-title":"Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism","volume":"91","author":"DeUgarte","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R52","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.2002.01603.x","article-title":"Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?","volume":"57","author":"Wijeyaratne","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613493549900_R54","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bmj.1.6171.1109","article-title":"Prevalence of facial acne vulgaris in late adolescence and in adults","volume":"1","author":"Cunliffe","year":"1979","journal-title":"Br Med J"},{"key":"2020071613493549900_R55","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2133.2004.06058.x","article-title":"Self-reported skin morbidity in Oslo. Associations with sociodemographic factors among adults in a cross-sectional study","volume":"151","author":"Dalgard","year":"2004","journal-title":"Br J Dermatol"},{"key":"2020071613493549900_R56","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2133.2005.06527.x","article-title":"Has acne increased? Prevalence of acne history among university students between 1948 and 1968. The Glasgow Alumni Cohort Study","volume":"152","author":"Galobardes","year":"2005","journal-title":"Br J Dermatol"},{"key":"2020071613493549900_R57","first-page":"1","article-title":"Skin conditions and related need for medical care among persons 1\u201374 years","author":"Johnson","year":"1978","journal-title":"United States, 1971\u20131974. Vital Health Stat 11:i-v"},{"key":"2020071613493549900_R58","first-page":"107","article-title":"Skin disease in Lambeth. A community study of prevalence and use of medical care","volume":"30","author":"Rea","year":"1976","journal-title":"Br J Prev Soc Med"},{"key":"2020071613493549900_R59","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0190-9622(88)70241-8","article-title":"The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia","volume":"19","author":"Futterweit","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"2020071613493549900_R60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2265.1994.tb02535.x","article-title":"A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia","volume":"41","author":"O\u2019Driscoll","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613493549900_R61","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1490439","article-title":"Prevalence of polycystic ovaries in women with androgenic alopecia","volume":"149","author":"Cela","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2020071613493549900_R62","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0015-0282(16)54353-2","article-title":"Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis","volume":"55","author":"Ardaens","year":"1991","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R63","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0015-0282(97)80068-4","article-title":"Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome","volume":"67","author":"van Santbrink","year":"1997","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R64","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/humrep\/16.7.1359","article-title":"Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility","volume":"16","author":"Laven","year":"2001","journal-title":"Hum Reprod"},{"key":"2020071613493549900_R65","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/humrep\/deg115","article-title":"Ultrasound examination of polycystic ovaries: is it worth counting the follicles?","volume":"18","author":"Jonard","year":"2003","journal-title":"Hum Reprod"},{"key":"2020071613493549900_R66","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.fertnstert.2004.12.061","article-title":"Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters","volume":"84","author":"Carmina","year":"2005","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R67","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/humrep\/dei159","article-title":"Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries","volume":"20","author":"Jonard","year":"2005","journal-title":"Hum Reprod"},{"key":"2020071613493549900_R68","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2020071613493549900_R69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1469-0705.1994.04010054.x","article-title":"Transabdominal versus transvaginal ultrasound in the diagnosis of polycystic ovaries in a population of randomly selected women","volume":"4","author":"Farquhar","year":"1994","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2020071613493549900_R70","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0015-0282(16)47838-6","article-title":"Hyperprolactinemia in polycystic ovary syndrome","volume":"41","author":"Luciano","year":"1984","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R71","first-page":"311","article-title":"Etiological review of hirsutism in 250 patients","volume":"25","author":"Moran","year":"1994","journal-title":"Arch Med Res"},{"key":"2020071613493549900_R72","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0015-0282(00)00566-5","article-title":"Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico","volume":"74","author":"Romaguera","year":"2000","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R73","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.fertnstert.2004.06.045","article-title":"Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome","volume":"82","author":"Escobar-Morreale","year":"2004","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R74","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/eje.0.1500363","article-title":"High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome","volume":"150","author":"Janssen","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2020071613493549900_R75","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.fertnstert.2004.06.040","article-title":"Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis","volume":"82","author":"Glintborg","year":"2004","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R76","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R77","first-page":"347","article-title":"Idiopathic hirsutism","volume":"21","author":"Azziz","year":"2000","journal-title":"Endocr Rev"},{"key":"2020071613493549900_R78","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1210\/jc.2004-2243","article-title":"Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome","volume":"90","author":"Wild","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R79","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/humrep\/12.5.905","article-title":"Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound","volume":"12","author":"Carmina","year":"1997","journal-title":"Hum Reprod"},{"key":"2020071613493549900_R80","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0015-0282(98)00455-5","article-title":"Do hyperandrogenic women with normal menses have polycystic ovary syndrome?","volume":"71","author":"Carmina","year":"1999","journal-title":"Fertil Steril"},{"key":"2020071613493549900_R81","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2006-1054","article-title":"Oligoanovulation with polycystic ovaries but not overt hyperandrogenism","volume":"91","author":"Dewailly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R82","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1993.tb02376.x","article-title":"The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries","volume":"39","author":"Robinson","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613493549900_R83","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"2020071613493549900_R84","first-page":"2694","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R85","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R86","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"2020071613493549900_R88","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2003-030617","article-title":"Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents","volume":"88","author":"Silfen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R89","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2003-031252","article-title":"Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity","volume":"89","author":"San Millan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R90","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.2337\/diabetes.53.9.2353","article-title":"Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome: phenotype and associated factors","volume":"53","author":"Gambineri","year":"2004","journal-title":"Diabetes"},{"key":"2020071613493549900_R91","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R92","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","author":"Dokras","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2020071613493549900_R93","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/jc.2004-2279","article-title":"Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters","volume":"90","author":"Carmina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R94","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R95","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2265.2001.01375.x","article-title":"Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight","volume":"55","author":"Michelmore","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613493549900_R96","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2004-0219","article-title":"Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613493549900_R97","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/oxfordjournals.humrep.a136280","article-title":"Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome","volume":"10","author":"Norman","year":"1995","journal-title":"Hum Reprod"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/11\/4237\/9060002\/jcem4237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/11\/4237\/9060002\/jcem4237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T20:44:45Z","timestamp":1594932285000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/91\/11\/4237\/2656314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":97,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-0178","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,1]]}}}